These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 16877352)
1. p62 ubiquitin binding-associated domain mediated the receptor activator of nuclear factor-kappaB ligand-induced osteoclast formation: a new insight into the pathogenesis of Paget's disease of bone. Yip KH; Feng H; Pavlos NJ; Zheng MH; Xu J Am J Pathol; 2006 Aug; 169(2):503-14. PubMed ID: 16877352 [TBL] [Abstract][Full Text] [Related]
2. A novel mutation (K378X) in the sequestosome 1 gene associated with increased NF-kappaB signaling and Paget's disease of bone with a severe phenotype. Rea SL; Walsh JP; Ward L; Yip K; Ward BK; Kent GN; Steer JH; Xu J; Ratajczak T J Bone Miner Res; 2006 Jul; 21(7):1136-45. PubMed ID: 16813535 [TBL] [Abstract][Full Text] [Related]
4. New insights into the role of sequestosome 1/p62 mutant proteins in the pathogenesis of Paget's disease of bone. Rea SL; Walsh JP; Layfield R; Ratajczak T; Xu J Endocr Rev; 2013 Aug; 34(4):501-24. PubMed ID: 23612225 [TBL] [Abstract][Full Text] [Related]
5. Sequestosome 1 mutations in Paget's disease of bone in Australia: prevalence, genotype/phenotype correlation, and a novel non-UBA domain mutation (P364S) associated with increased NF-kappaB signaling without loss of ubiquitin binding. Rea SL; Walsh JP; Ward L; Magno AL; Ward BK; Shaw B; Layfield R; Kent GN; Xu J; Ratajczak T J Bone Miner Res; 2009 Jul; 24(7):1216-23. PubMed ID: 19257822 [TBL] [Abstract][Full Text] [Related]
6. The p62 P392L mutation linked to Paget's disease induces activation of human osteoclasts. Chamoux E; Couture J; Bisson M; Morissette J; Brown JP; Roux S Mol Endocrinol; 2009 Oct; 23(10):1668-80. PubMed ID: 19589897 [TBL] [Abstract][Full Text] [Related]
7. A SQSTM1/p62 mutation linked to Paget's disease increases the osteoclastogenic potential of the bone microenvironment. Hiruma Y; Kurihara N; Subler MA; Zhou H; Boykin CS; Zhang H; Ishizuka S; Dempster DW; Roodman GD; Windle JJ Hum Mol Genet; 2008 Dec; 17(23):3708-19. PubMed ID: 18765443 [TBL] [Abstract][Full Text] [Related]
8. Structure of the ubiquitin-associated domain of p62 (SQSTM1) and implications for mutations that cause Paget's disease of bone. Ciani B; Layfield R; Cavey JR; Sheppard PW; Searle MS J Biol Chem; 2003 Sep; 278(39):37409-12. PubMed ID: 12857745 [TBL] [Abstract][Full Text] [Related]
9. A point mutation in the ubiquitin-associated domain of SQSMT1 is sufficient to cause a Paget's disease-like disorder in mice. Daroszewska A; van 't Hof RJ; Rojas JA; Layfield R; Landao-Basonga E; Rose L; Rose K; Ralston SH Hum Mol Genet; 2011 Jul; 20(14):2734-44. PubMed ID: 21515589 [TBL] [Abstract][Full Text] [Related]
10. p62 mutations, ubiquitin recognition and Paget's disease of bone. Layfield R; Cavey JR; Najat D; Long J; Sheppard PW; Ralston SH; Searle MS Biochem Soc Trans; 2006 Nov; 34(Pt 5):735-7. PubMed ID: 17052185 [TBL] [Abstract][Full Text] [Related]
11. Characterization of a non-UBA domain missense mutation of sequestosome 1 (SQSTM1) in Paget's disease of bone. Najat D; Garner T; Hagen T; Shaw B; Sheppard PW; Falchetti A; Marini F; Brandi ML; Long JE; Cavey JR; Searle MS; Layfield R J Bone Miner Res; 2009 Apr; 24(4):632-42. PubMed ID: 19049332 [TBL] [Abstract][Full Text] [Related]
12. Paget disease of bone-associated UBA domain mutations of SQSTM1 exert distinct effects on protein structure and function. Goode A; Long JE; Shaw B; Ralston SH; Visconti MR; Gianfrancesco F; Esposito T; Gennari L; Merlotti D; Rendina D; Rea SL; Sultana M; Searle MS; Layfield R Biochim Biophys Acta; 2014 Jul; 1842(7):992-1000. PubMed ID: 24642144 [TBL] [Abstract][Full Text] [Related]
15. Impact of p62/SQSTM1 UBA domain mutations linked to Paget's disease of bone on ubiquitin recognition. Garner TP; Long J; Layfield R; Searle MS Biochemistry; 2011 May; 50(21):4665-74. PubMed ID: 21517082 [TBL] [Abstract][Full Text] [Related]
16. Novel UBA domain mutations of SQSTM1 in Paget's disease of bone: genotype phenotype correlation, functional analysis, and structural consequences. Hocking LJ; Lucas GJ; Daroszewska A; Cundy T; Nicholson GC; Donath J; Walsh JP; Finlayson C; Cavey JR; Ciani B; Sheppard PW; Searle MS; Layfield R; Ralston SH J Bone Miner Res; 2004 Jul; 19(7):1122-7. PubMed ID: 15176995 [TBL] [Abstract][Full Text] [Related]
18. A FKBP5 mutation is associated with Paget's disease of bone and enhances osteoclastogenesis. Lu B; Jiao Y; Wang Y; Dong J; Wei M; Cui B; Sun Y; Wang L; Zhang B; Chen Z; Zhao Y Exp Mol Med; 2017 May; 49(5):e336. PubMed ID: 28524179 [TBL] [Abstract][Full Text] [Related]
19. Genetics of Paget's disease of bone. Daroszewska A; Ralston SH Clin Sci (Lond); 2005 Sep; 109(3):257-63. PubMed ID: 16104845 [TBL] [Abstract][Full Text] [Related]
20. Involvement of kinase PKC-zeta in the p62/p62(P392L)-driven activation of NF-κB in human osteoclasts. Chamoux E; McManus S; Laberge G; Bisson M; Roux S Biochim Biophys Acta; 2013 Mar; 1832(3):475-84. PubMed ID: 23266528 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]